Ran Afik

653 total citations
9 papers, 451 citations indexed

About

Ran Afik is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ran Afik has authored 9 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Ran Afik's work include T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Ran Afik is often cited by papers focused on T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Ran Afik collaborates with scholars based in Israel, United States and Germany. Ran Afik's co-authors include Elad Bassat, Irit Sagi, Chen Varol, Ehud Zigmond, Mordehay Klepfish, Anjana Shenoy, Metsada Pasmanik‐Chor, Elee Shimshoni, Zamir Halpern and Tamar Geiger and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Cancer Research.

In The Last Decade

Ran Afik

9 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Afik Israel 6 232 201 142 70 67 9 451
Kerstin Schlüter Germany 9 109 0.5× 267 1.3× 191 1.3× 86 1.2× 100 1.5× 9 505
Jill M. Westcott United States 12 131 0.6× 239 1.2× 238 1.7× 108 1.5× 93 1.4× 16 505
Casey W. Shuptrine United States 10 294 1.3× 264 1.3× 225 1.6× 43 0.6× 21 0.3× 13 588
Aviad Ben‐Shmuel Israel 10 354 1.5× 385 1.9× 249 1.8× 118 1.7× 68 1.0× 12 716
Marcin Ziętek Poland 12 137 0.6× 245 1.2× 200 1.4× 104 1.5× 41 0.6× 57 487
Yasuko Kinoshita Japan 13 275 1.2× 146 0.7× 328 2.3× 53 0.8× 68 1.0× 26 654
Bastian Seubert Germany 7 133 0.6× 194 1.0× 300 2.1× 238 3.4× 47 0.7× 8 534
Joakim Karlsson Sweden 13 176 0.8× 278 1.4× 272 1.9× 120 1.7× 31 0.5× 24 572
Willem Maat Netherlands 14 186 0.8× 179 0.9× 275 1.9× 62 0.9× 66 1.0× 15 620

Countries citing papers authored by Ran Afik

Since Specialization
Citations

This map shows the geographic impact of Ran Afik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Afik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Afik more than expected).

Fields of papers citing papers by Ran Afik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Afik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Afik. The network helps show where Ran Afik may publish in the future.

Co-authorship network of co-authors of Ran Afik

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Afik. A scholar is included among the top collaborators of Ran Afik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Afik. Ran Afik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wolach, Ofir, Itai Levi, Jonathan Canaani, et al.. (2020). First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study. Blood. 136(Supplement 1). 27–28. 3 indexed citations
2.
Weil, Clara, Gabriel Chodick, Varda Shalev, et al.. (2020). Epidemiology, longitudinal treatment patterns and outcomes of chronic lymphocytic leukemia in Israel. Leukemia & lymphoma. 62(5). 1136–1145. 5 indexed citations
3.
Grossman, Moran, Nir Ben‐Chetrit, Alina Zhuravlev, et al.. (2016). Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix. Cancer Research. 76(14). 4249–4258. 102 indexed citations
4.
Afik, Ran, Ehud Zigmond, Mordehay Klepfish, et al.. (2016). Tumor macrophages are pivotal constructors of tumor collagenous matrix. The Journal of Experimental Medicine. 213(11). 2315–2331. 268 indexed citations
5.
Ophir, Eran, Ran Afik, Shlomit Reich-Zeliger, et al.. (2013). A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells. Blood. 121(15). 3033–3040. 3 indexed citations
6.
7.
Milstein, Oren, David Hagin, Shlomit Reich-Zeliger, et al.. (2010). CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood. 117(3). 1042–1052. 39 indexed citations
8.
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin Schlüter Breakdown of academic impact, for papers by Jill M. Westcott Breakdown of academic impact, for papers by Casey W. Shuptrine Breakdown of academic impact, for papers by Aviad Ben‐Shmuel Breakdown of academic impact, for papers by Marcin Ziętek Breakdown of academic impact, for papers by Yasuko Kinoshita Breakdown of academic impact, for papers by Bastian Seubert Breakdown of academic impact, for papers by Joakim Karlsson Breakdown of academic impact, for papers by Willem Maat
Rankless by CCL
2026